Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration

JAMA Ophthalmology

Volumn 132, Issue 5, 2014, Pages 528-534

  Caire, Josemaria ^a,b   Recalde, Sergio ^a   Velazquez Villoria, Alvaro ^a,b   Garcia Garcia, Laura ^a   Reiter, Nicholas ^a   Anter, Jaouad ^c   Fernandez Robredo, Patricia ^a   García Layana, Alfredo ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; C3 PROTEIN; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED 1; DNA; FRH 3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; FUNDUS AUTOFLUORESCENCE IMAGING; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GEOGRAPHIC ATROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; BLOOD PROTEINS; COMPLEMENT C3; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT FACTOR B; COMPLEMENT FACTOR H; DISEASE PROGRESSION; DNA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GEOGRAPHIC ATROPHY; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; OPTICAL IMAGING; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROTEINS;

EID: 84900433175     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.8175     Document Type: Article

References (30)

1. Thakkinstian A, Han P, McEvoy M, et al. Systematic review and meta-Analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet. 2006;15(18):2784-2790.
2. Klein R, Meuer SM, Knudtson MD, Klein BE. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol. 2008;146(5):692-699.
3. Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration: clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol. 1998;116(8):1082-1088.
4. Abdelsalam A, Del Priore L, ZarbinMA. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol. 1999;44(1):1-29.
5. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol. 1999;83(3):358-368.
6. Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM. Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci. 2012;53(3):1548-1556.
7. Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration. Neuron. 2012;75(1):26-39.
8. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S; FAM-Study Group. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol. 2007;143(3):463-472.
9. Klein ML, Ferris FL III, Francis PJ, et al. Progression of geographic atrophy and genotype in age-related macular degeneration. Ophthalmology. 2010;117(8):1554-1559, e1.
10. Scholl HP, Fleckenstein M, Fritsche LG, et al. CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One. 2009;4(10):e7418.
11. Fleckenstein M, Schmitz-Valckenberg S, Adrion C, et al; FAM Study Group. Progression of age-related geographic atrophy: role of the fellow eye. Invest Ophthalmol Vis Sci. 2011;52(9):6552-6557.
12. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, NasirMA, GiustMJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113(3):363-372, e5.
13. Schmidt S, Hauser MA, Scott WK, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet. 2006;78(5): 852-864.
14. SmithW, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108(4):697-704.
15. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study: Age-Related Eye Disease Study report number 3. Ophthalmology. 2000;107(12):2224-2232.
16. Seddon JM, George S, Rosner B, KleinML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered. 2006;61(3):157-165.
17. Luo L, Harmon J, Yang X, et al. Familial aggregation of age-related macular degeneration in the Utah population. Vision Res. 2008;48(3): 494-500.
18. Garcia Layana A, Zarranz-Ventura J, Fernandez Robredo P, Recalde S, Rodriguez de Cordoba S; Grupo Espanol de Investigacion Cooperativa en DMAE. Genetics and ARMD: from the laboratory to the consulting room [in Spanish]. Arch Soc Esp Oftalmol. 2011;86(4):101-102.
19. Martinez-Barricarte R, Recalde S, Fernandez-Robredo P, et al; Spanish Multicenter Group on AMD. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2012;53(3):1087-1094.
20. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385-389.
21. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14(21):3227-3236.
22. Recalde S, Fernandez-Robredo P, AltarribaM, Salinas-Alaman A, Garcia-Layana A. Age-related macular degeneration genetics. Ophthalmology. 2008;115(5):916; e1.
23. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a reviewof progress to date. Surv Ophthalmol. 2006;51(4):316-363.
24. Maller J, George S, Purcell S, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet. 2006;38(9):1055-1059.
25. Francis PJ, Hamon SC, Ott J,Weleber RG, Klein ML. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Genet. 2009;46(5):300-307.
26. Schmitz-Valckenberg S, Brinkmann CK, Alten F, et al. Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(10):7640-7646.
27. Bearelly S, Cousins SW. Fundus autofluorescence imaging in age-related macular degeneration and geographic atrophy. Adv Exp Med Biol. 2010;664:395-402.
28. Lindblad AS, Lloyd PC, Clemons TE, et al; Age-Related Eye Disease Study Research Group. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. 2009;127(9):1168-1174.
29. Seddon JM, Francis PJ, George S, Schultz DW, Rosner B, KleinML. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA. 2007;297(16):1793-1800.
30. Yu Y, Reynolds R, Fagerness J, Rosner B, Daly MJ, Seddon JM. Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(7):4663-4670.